In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...

New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

Pathway-focused metabolite ratio-based analysis of 49 tumor and 8 normal epithelial cell lines grown in their respective ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Multi-omics analysis of human kidney PDGFRβ+ mesenchymal cells quantified over 14,000 biomolecules across 8 time points, ...